PT-141
Bremelanotide, a melanocortin receptor agonist studied for MC3R/MC4R signaling in the central nervous system.
Clicking this button will open your email client to send your order to [email protected]
Specifications
Purity
>=98%
Concentration
10mg
Molecular Weight
1025.2 Da
Form
Lyophilized Powder
Storage
-20°C, protected from light
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist. Unlike other compounds in its class, PT-141 acts on the nervous system rather than the vascular system, making it unique in its mechanism of action. Research has focused on its activation of MC3R and MC4R receptors in the central nervous system, with studies investigating neuropeptide signaling pathways, receptor binding kinetics, and melanocortin cascade mechanisms. It is a significant compound in neuropharmacological research.
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OHThis product has been COA tested, confirming identity, purity (via HPLC), and molecular weight (via mass spectrometry).
This product is intended for laboratory research use only. It is not a drug, food, or diagnostic device and has not been approved by the FDA for human or veterinary use. It must not be introduced into any living organism or used for any non-research purpose.